Original Literature | Model OverView |
---|---|
Publication
Title
Innate immunity minireview series: making biochemical sense of nucleic acidsensors that trigger antiviral innate immunity.
Affiliation
Department of Molecular, Cellular, and Developmental Biology and theBiomolecular Sciences and Engineering Program, University of California, SantaBarbara, California 93106, USA. samuel@lifesci.ucsb.edu
Abstract
PMID
17395579
|
Entity
--
e1
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane
--
--
--
csml-variable:Double
m1
0
infinite
0
--
--
e10
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cytosol
--
--
--
csml-variable:Double
m10
0
infinite
0
--
--
e11
cso30:c:EntityBiologicalCompartment
cso30:i:CC_EndosomeLumen
--
--
--
csml-variable:Double
m11
0
infinite
0
--
TLR7
--
e12
cso30:c:Protein
cso30:i:CC_EndosomeLumen
--
--
csml-variable:Double
m12
0
infinite
0
--
TLR8
--
e13
cso30:c:Protein
cso30:i:CC_EndosomeLumen
--
--
csml-variable:Double
m13
0
infinite
0
--
TLR9
--
e14
cso30:c:Protein
cso30:i:CC_EndosomeLumen
--
--
csml-variable:Double
m14
0
infinite
0
--
csml-variable:Double
m15
0
infinite
0
--
csml-variable:Double
m16
0
infinite
0
--
CpG DNA: TLR9
--
e17
cso30:c:Complex
cso30:i:CC_EndosomeMembrane
--
csml-variable:Double
m17
0
infinite
0
--
ssRNA: TLR7: MyD88
--
e18
cso30:c:Complex
cso30:i:CC_EndosomeLumen
--
csml-variable:Double
m18
0
infinite
0
--
ssRNA: TLR8: MyD88
--
e19
cso30:c:Complex
cso30:i:CC_EndosomeMembrane
--
csml-variable:Double
m19
0
infinite
0
--
--
e2
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_ExternalSideOfPlasmaMembrane_
--
--
--
csml-variable:Double
m2
0
infinite
0
--
CpG DNA: TLR9: MyD88
--
e20
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m20
0
infinite
0
--
MyD88
--
e21
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m21
0
infinite
0
--
ssRNA
--
e22
cso30:c:RnaOther
cso30:i:CC_Cytosol
--
csml-variable:Double
m22
0
infinite
0
--
csml-variable:Double
m23
0
infinite
0
--
dsRNA
--
e24
cso30:c:RnaOther
cso30:i:CC_Extracellular
--
csml-variable:Double
m24
0
infinite
0
--
TLR3
--
e25
cso30:c:Protein
cso30:i:CC_EndosomeLumen
--
--
csml-variable:Double
m25
0
infinite
0
--
dsRNA: TLR3
--
e26
cso30:c:Complex
cso30:i:CC_EndosomeLumen
--
csml-variable:Double
m26
0
infinite
0
--
TRIF
--
e27
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m27
0
infinite
0
--
dsRNA: TLR3: TRIF
--
e28
cso30:c:Complex
cso30:i:CC_EndosomeLumen
--
csml-variable:Double
m28
0
infinite
0
--
RIG-1
--
e29
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m29
0
infinite
0
--
--
e3
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
--
csml-variable:Double
m3
0
infinite
0
--
Mda-5
--
e30
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m30
0
infinite
0
--
csml-variable:Double
m31
0
infinite
0
--
csml-variable:Double
m32
0
infinite
0
--
--
e33
cso30:c:EntityBiologicalCompartment
cso30:i:CC_MitochondrialChromosome
--
--
--
csml-variable:Double
m33
0
infinite
0
--
--
e34
cso30:c:EntityBiologicalCompartment
cso30:i:CC_MitochondrialCentromere
--
--
--
csml-variable:Double
m34
0
infinite
0
--
--
e35
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Mitochondria
--
--
--
csml-variable:Double
m35
0
infinite
0
--
--
e36
cso30:c:EntityBiologicalCompartment
cso30:i:CC_MitochondrialIntermembraneSpace
--
--
--
csml-variable:Double
m36
0
infinite
0
--
--
e37
cso30:c:EntityBiologicalCompartment
cso30:i:CC_MitochondrialEnvelope
--
--
--
csml-variable:Double
m37
0
infinite
0
--
--
e38
cso30:c:EntityBiologicalCompartment
cso30:i:CC_MitochondrialInnerMembrane
--
--
--
csml-variable:Double
m38
0
infinite
0
--
--
e39
cso30:c:EntityBiologicalCompartment
cso30:i:CC_MitochondrialOuterMembrane
--
--
--
csml-variable:Double
m39
0
infinite
0
--
--
e4
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_InternalSideOfPlasmaMembrane_
--
--
--
csml-variable:Double
m4
0
infinite
0
--
--
e40
cso30:c:EntityBiologicalCompartment
cso30:i:CC_MitochondrialLumen
--
--
--
csml-variable:Double
m40
0
infinite
0
--
--
e41
cso30:c:EntityBiologicalCompartment
cso30:i:CC_MitochondrialMatrix
--
--
--
csml-variable:Double
m41
0
infinite
0
--
IPS-1
--
e42
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m42
0
infinite
0
--
dsRNA: RIG-1: IPS-1
--
e43
cso30:c:Complex
cso30:i:CC_MitochondrialIntermembraneSpace
--
csml-variable:Double
m43
0
infinite
0
--
dsRNA: Mda-5: IPS-1
--
e44
cso30:c:Complex
cso30:i:CC_MitochondrialIntermembraneSpace
--
csml-variable:Double
m44
0
infinite
0
--
TRAF3
--
e45
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m45
0
infinite
0
--
TRAF3{activated}
--
e46
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m46
0
infinite
0
--
TBK-1: IKK-i
--
e47
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m47
0
infinite
0
--
TBK-1: IKK-i{activated}
--
e48
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m48
0
infinite
0
--
IRF-3
--
e49
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m49
0
infinite
0
--
--
e5
cso30:c:EntityBiologicalCompartment
cso30:i:CC_EndosomeMembrane
--
--
--
csml-variable:Double
m5
0
infinite
0
--
--
e50
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearEnvelopeLumen
--
--
--
csml-variable:Double
m50
0
infinite
0
--
--
e51
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearPore
--
--
--
csml-variable:Double
m51
0
infinite
0
--
--
e52
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearInnerMembrane
--
--
--
csml-variable:Double
m52
0
infinite
0
--
--
e53
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearLumen
--
--
--
csml-variable:Double
m53
0
infinite
0
--
--
e54
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearOuterMembrane
--
--
--
csml-variable:Double
m54
0
infinite
0
--
--
e55
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleus
--
--
--
csml-variable:Double
m55
0
infinite
0
--
--
e56
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleoplasm
--
--
--
csml-variable:Double
m56
0
infinite
0
--
--
e57
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearBody
--
--
--
csml-variable:Double
m57
0
infinite
0
--
--
e58
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleolus
--
--
--
csml-variable:Double
m58
0
infinite
0
--
--
e59
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearEnvelope
--
--
--
csml-variable:Double
m59
0
infinite
0
--
--
e6
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Endosome
--
--
--
csml-variable:Double
m6
0
infinite
0
--
--
e60
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Chromatin
--
--
--
csml-variable:Double
m60
0
infinite
0
--
--
e61
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearChromosome
--
--
--
csml-variable:Double
m61
0
infinite
0
--
--
e62
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearCentromere
--
--
--
csml-variable:Double
m62
0
infinite
0
--
IRF-3{activated}
--
e63
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m63
0
infinite
0
--
IRF-7
--
e64
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m64
0
infinite
0
--
IRF-7{activated}
--
e65
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m65
0
infinite
0
--
IKK-alpha: IKK-beta: IKK-gamma
--
e66
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m66
0
infinite
0
--
IKK-alpha: IKK-beta: IKK-gamma{activated}
--
e67
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m67
0
infinite
0
--
NF-kappaB
--
e68
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m68
0
infinite
0
--
NF-kappaB{activated}
--
e69
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m69
0
infinite
0
--
--
e7
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cell
--
--
--
csml-variable:Double
m7
0
infinite
0
--
IRAK1: IRAK4
--
e70
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m70
0
infinite
0
--
IRAK1: IRAK4{activated}
--
e71
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m71
0
infinite
0
--
TRAF6
--
e72
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m72
0
infinite
0
--
TRAF6{activated}
--
e73
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m73
0
infinite
0
--
IRF-3: IRF-7 {activated}
--
e74
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m74
0
infinite
0
--
IRF-3: IRF-7 {nuclear}
--
e75
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m75
0
infinite
0
--
IFN-beta
--
e76
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
csml-variable:Double
m76
0
infinite
0
--
NF-kappaB{nucleus}
--
e77
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m77
0
infinite
0
--
IFN-alpha4
--
e78
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
csml-variable:Double
m78
0
infinite
0
--
--
e8
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cell_WithoutCellWall_
--
--
--
csml-variable:Double
m8
0
infinite
0
--
--
e9
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cytoplasm
--
--
--
csml-variable:Double
m9
0
infinite
0
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c4 : 1
stoichiometry:c17 : 1
stoichiometry:c5 : 1
m12*m22*0.1
nodelay
--
0
PMID: 17395579 TLR7 and -8 (when activated by ssRNA) and TLR9 (when activated by CpG-rich DNA) mediate MyD88-dependent adaptor signaling.
p10
p10
cso30:i:ME_Binding
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c25 : 1
stoichiometry:c27 : 1
stoichiometry:c28 : 1
m24*m29*0.1
nodelay
--
0
PMID: 17395579 The interaction of RNA with the RIG-I or MDA5 cytosolic cellular helicase mediates signaling via CARD domain interactions between the helicase sensor and a mitochondrial membrane-associated adaptor protein known variously as IPS-1, CARDIF, MAVS, and VISA.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c31 : 1
stoichiometry:c32 : 1
stoichiometry:c33 : 1
m31*m42*0.1
nodelay
--
0
PMID: 17395579 The interaction of RNA with the RIG-I or MDA5 cytosolic cellular helicase mediates signaling via CARD domain interactions between the helicase sensor and a mitochondrial membrane-associated adaptor protein known variously as IPS-1, CARDIF, MAVS, and VISA.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c34 : 1
stoichiometry:c35 : 1
stoichiometry:c36 : 1
m42*m32*0.1
nodelay
--
0
PMID: 17395579 The interaction of RNA with the RIG-I or MDA5 cytosolic cellular helicase mediates signaling via CARD domain interactions between the helicase sensor and a mitochondrial membrane-associated adaptor protein known variously as IPS-1, CARDIF, MAVS, and VISA.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c37 : 1
stoichiometry:c39 : 1
stoichiometry:c38 : 1
m45*m28*0.1
nodelay
--
0
PMID: 17395579 The IPS-1, TRIF, and MyD88 adaptors then lead to IRF and NF-kappaB activation via IKK (inhibitor of nuclear factor-{kappa}B kinase), IRAK (interleukin 1 receptor-associated kinase), TBK (TANK-binding kinase), and TRAF (tumor necrosis factor receptor-associated factor) proteins.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c40 : 1
stoichiometry:c42 : 1
stoichiometry:c41 : 1
m47*m46*0.1
nodelay
--
0
PMID: 17395579 The IPS-1, TRIF, and MyD88 adaptors then lead to IRF and NF-kappaB activation via IKK (inhibitor of nuclear factor-{kappa}B kinase), IRAK (interleukin 1 receptor-associated kinase), TBK (TANK-binding kinase), and TRAF (tumor necrosis factor receptor-associated factor) proteins.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c43 : 1
stoichiometry:c47 : 1
stoichiometry:c44 : 1
m49*m48*0.1
nodelay
--
0
PMID: 17395579 The IPS-1, TRIF, and MyD88 adaptors then lead to IRF and NF-kappaB activation via IKK (inhibitor of nuclear factor-{kappa}B kinase), IRAK (interleukin 1 receptor-associated kinase), TBK (TANK-binding kinase), and TRAF (tumor necrosis factor receptor-associated factor) proteins.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c45 : 1
stoichiometry:c48 : 1
stoichiometry:c46 : 1
m64*m48*0.1
nodelay
--
0
PMID: 17395579 The IPS-1, TRIF, and MyD88 adaptors then lead to IRF and NF-kappaB activation via IKK (inhibitor of nuclear factor-{kappa}B kinase), IRAK (interleukin 1 receptor-associated kinase), TBK (TANK-binding kinase), and TRAF (tumor necrosis factor receptor-associated factor) proteins.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c49 : 1
stoichiometry:c50 : 1
stoichiometry:c51 : 1
m28*m66*0.1
nodelay
--
0
PMID: 17395579 The IPS-1, TRIF, and MyD88 adaptors then lead to IRF and NF-kappaB activation via IKK (inhibitor of nuclear factor-{kappa}B kinase), IRAK (interleukin 1 receptor-associated kinase), TBK (TANK-binding kinase), and TRAF (tumor necrosis factor receptor-associated factor) proteins.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c52 : 1
stoichiometry:c54 : 1
stoichiometry:c53 : 1
m68*m67*0.1
nodelay
--
0
PMID: 17395579 The IPS-1, TRIF, and MyD88 adaptors then lead to IRF and NF-kappaB activation via IKK (inhibitor of nuclear factor-{kappa}B kinase), IRAK (interleukin 1 receptor-associated kinase), TBK (TANK-binding kinase), and TRAF (tumor necrosis factor receptor-associated factor) proteins.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c55 : 1
stoichiometry:c61 : 1
stoichiometry:c56 : 1
m70*m18*0.1
nodelay
--
0
PMID: 17395579 The IPS-1, TRIF, and MyD88 adaptors then lead to IRF and NF-kappaB activation via IKK (inhibitor of nuclear factor-{kappa}B kinase), IRAK (interleukin 1 receptor-associated kinase), TBK (TANK-binding kinase), and TRAF (tumor necrosis factor receptor-associated factor) proteins.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c1 : 1
stoichiometry:c6 : 1
stoichiometry:c7 : 1
m21*m15*0.1
nodelay
--
0
PMID: 17395579 TLR7 and -8 (when activated by ssRNA) and TLR9 (when activated by CpG-rich DNA) mediate MyD88-dependent adaptor signaling.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c57 : 1
stoichiometry:c62 : 1
stoichiometry:c58 : 1
m70*m19*0.1
nodelay
--
0
PMID: 17395579 The IPS-1, TRIF, and MyD88 adaptors then lead to IRF and NF-kappaB activation via IKK (inhibitor of nuclear factor-{kappa}B kinase), IRAK (interleukin 1 receptor-associated kinase), TBK (TANK-binding kinase), and TRAF (tumor necrosis factor receptor-associated factor) proteins.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c59 : 1
stoichiometry:c63 : 1
stoichiometry:c60 : 1
m70*m20*0.1
nodelay
--
0
PMID: 17395579 The IPS-1, TRIF, and MyD88 adaptors then lead to IRF and NF-kappaB activation via IKK (inhibitor of nuclear factor-{kappa}B kinase), IRAK (interleukin 1 receptor-associated kinase), TBK (TANK-binding kinase), and TRAF (tumor necrosis factor receptor-associated factor) proteins.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c64 : 1
stoichiometry:c66 : 1
stoichiometry:c65 : 1
m72*m71*0.1
nodelay
--
0
PMID: 17395579 The IPS-1, TRIF, and MyD88 adaptors then lead to IRF and NF-kappaB activation via IKK (inhibitor of nuclear factor-{kappa}B kinase), IRAK (interleukin 1 receptor-associated kinase), TBK (TANK-binding kinase), and TRAF (tumor necrosis factor receptor-associated factor) proteins.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c67 : 1
stoichiometry:c69 : 1
stoichiometry:c68 : 1
m64*m73*0.1
nodelay
--
0
PMID: 17395579 The IPS-1, TRIF, and MyD88 adaptors then lead to IRF and NF-kappaB activation via IKK (inhibitor of nuclear factor-{kappa}B kinase), IRAK (interleukin 1 receptor-associated kinase), TBK (TANK-binding kinase), and TRAF (tumor necrosis factor receptor-associated factor) proteins.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c70 : 1
stoichiometry:c71 : 1
stoichiometry:c72 : 1
m63*m65*0.1
nodelay
--
0
PMID: 17395579 The IPS-1, TRIF, and MyD88 adaptors then lead to IRF and NF-kappaB activation via IKK (inhibitor of nuclear factor-{kappa}B kinase), IRAK (interleukin 1 receptor-associated kinase), TBK (TANK-binding kinase), and TRAF (tumor necrosis factor receptor-associated factor) proteins.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c73 : 1
stoichiometry:c74 : 1
m74*0.1
nodelay
--
0
PMID: 17395579 Translocation into the nucleus of IRF dimers (IRF-3, IRF-7) and activated NF-kappaB lead to transcriptional activation of type I interferon gene expression (for example IFN-beta and IFN-alpha4).
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c75 : 1
stoichiometry:c76 : 1
m75*0.1
nodelay
--
0
PMID: 17395579 Translocation into the nucleus of IRF dimers (IRF-3, IRF-7) and activated NF-kappaB lead to transcriptional activation of type I interferon gene expression (for example IFN-beta and IFN-alpha4).
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c77 : 1
stoichiometry:c82 : 1
stoichiometry:c78 : 1
m45*m44*0.1
nodelay
--
0
PMID: 17395579 The IPS-1, TRIF, and MyD88 adaptors then lead to IRF and NF-kappaB activation via IKK (inhibitor of nuclear factor-{kappa}B kinase), IRAK (interleukin 1 receptor-associated kinase), TBK (TANK-binding kinase), and TRAF (tumor necrosis factor receptor-associated factor) proteins.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c79 : 1
stoichiometry:c81 : 1
stoichiometry:c80 : 1
m45*m43*0.1
nodelay
--
0
PMID: 17395579 The IPS-1, TRIF, and MyD88 adaptors then lead to IRF and NF-kappaB activation via IKK (inhibitor of nuclear factor-{kappa}B kinase), IRAK (interleukin 1 receptor-associated kinase), TBK (TANK-binding kinase), and TRAF (tumor necrosis factor receptor-associated factor) proteins.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c83 : 1
stoichiometry:c84 : 1
m69*0.1
nodelay
--
0
PMID: 17395579 Translocation into the nucleus of IRF dimers (IRF-3, IRF-7) and activated NF-kappaB lead to transcriptional activation of type I interferon gene expression (for example IFN-beta and IFN-alpha4).
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c8 : 1
stoichiometry:c16 : 1
stoichiometry:c9 : 1
m13*m22*0.1
nodelay
--
0
PMID: 17395579 TLR7 and -8 (when activated by ssRNA) and TLR9 (when activated by CpG-rich DNA) mediate MyD88-dependent adaptor signaling.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c86 : 1
stoichiometry:c88 : 1
m77*0.1
nodelay
--
0
PMID: 17395579 Translocation into the nucleus of IRF dimers (IRF-3, IRF-7) and activated NF-kappaB lead to transcriptional activation of type I interferon gene expression (for example IFN-beta and IFN-alpha4).
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c85 : 1
stoichiometry:c89 : 1
m75*0.1
nodelay
--
0
PMID: 17395579 Translocation into the nucleus of IRF dimers (IRF-3, IRF-7) and activated NF-kappaB lead to transcriptional activation of type I interferon gene expression (for example IFN-beta and IFN-alpha4).
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c87 : 1
stoichiometry:c90 : 1
m77*0.1
nodelay
--
0
PMID: 17395579 Translocation into the nucleus of IRF dimers (IRF-3, IRF-7) and activated NF-kappaB lead to transcriptional activation of type I interferon gene expression (for example IFN-beta and IFN-alpha4).
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c12 : 1
stoichiometry:c18 : 1
stoichiometry:c13 : 1
m14*m23*0.1
nodelay
--
0
PMID: 17395579 TLR7 and -8 (when activated by ssRNA) and TLR9 (when activated by CpG-rich DNA) mediate MyD88-dependent adaptor signaling.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c2 : 1
stoichiometry:c10 : 1
stoichiometry:c11 : 1
m21*m16*0.1
nodelay
--
0
PMID: 17395579 TLR7 and -8 (when activated by ssRNA) and TLR9 (when activated by CpG-rich DNA) mediate MyD88-dependent adaptor signaling.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c3 : 1
stoichiometry:c14 : 1
stoichiometry:c15 : 1
m21*m17*0.1
nodelay
--
0
PMID: 17395579 TLR7 and -8 (when activated by ssRNA) and TLR9 (when activated by CpG-rich DNA) mediate MyD88-dependent adaptor signaling.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c19 : 1
stoichiometry:c20 : 1
stoichiometry:c21 : 1
m25*m24*0.1
nodelay
--
0
PMID: 17395579 TLR3 when activated by dsRNA mediates MyD88-independent signaling via the TRIF adaptor protein.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c22 : 1
stoichiometry:c23 : 1
stoichiometry:c24 : 1
m26*m27*0.1
nodelay
--
0
PMID: 17395579 TLR3 when activated by dsRNA mediates MyD88-independent signaling via the TRIF adaptor protein.
p9
p9
cso30:i:ME_Binding
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c26 : 1
stoichiometry:c29 : 1
stoichiometry:c30 : 1
m24*m30*0.1
nodelay
--
0
PMID: 17395579 The interaction of RNA with the RIG-I or MDA5 cytosolic cellular helicase mediates signaling via CARD domain interactions between the helicase sensor and a mitochondrial membrane-associated adaptor protein known variously as IPS-1, CARDIF, MAVS, and VISA.
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--